Reviva Pharmaceuticals (RVPH) Institutional Ownership $1.34 -0.16 (-10.67%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$6.23MNumber ofInstitutional Sellers(last 12 months)0 Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Ad Porter & CompanyAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC278,496$401K0.0%+17.9%0.833% 5/10/2024 Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588% 2/13/2024 Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023 Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023 EMC Capital Management123,915$613K0.4%+1,294.3%0.547% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023 Virtu Financial LLC18,448$108K0.0%N/A0.090% 2/15/2023 Tang Capital Management LLC24,125$103K0.0%N/A0.118% 2/13/2023 EMC Capital Management123,915$527K0.5%+125.0%0.606% 2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/7/2022 Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161% 2/10/2022 EMC Capital Management55,078$159K0.1%-27.4%0.364% 2/3/2022 Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241% 8/17/2021 Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021 Renaissance Technologies LLC11,250$55K0.0%N/A0.122% 8/13/2021 Northern Trust Corp10,584$51K0.0%N/A0.115% 8/13/2021 Geode Capital Management LLC67,724$329K0.0%N/A0.734% 8/13/2021 Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108% 5/21/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% 5/18/2021 Millennium Management LLC35,310$203K0.0%N/A0.382% 5/18/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% 4/28/2021 DAVENPORT & Co LLC15,000$86K0.0%N/A0.162% (Data available from 1/1/2016 forward) RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, the following institutional investors and hedge funds held shares of Reviva Pharmaceuticals shares: Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), EMC Capital Management ($613K), Geode Capital Management LLC ($401K), Virtu Financial LLC ($108K), Tang Capital Management LLC ($103K), and Wolverine Asset Management LLC ($85K).Learn more on RVPH's institutional investors. What percentage of Reviva Pharmaceuticals stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals stock? The following institutional investors have purchased Reviva Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($1.16M), EMC Capital Management ($183.87K), Geode Capital Management LLC ($42.38K), Vanguard Group Inc. ($26.85K), Tang Capital Management LLC ($24.13K), Virtu Financial LLC ($18.45K), and Wolverine Asset Management LLC ($14.55K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 1,488,220 shares in the last 24 months. This purchase volume represents approximately $7.37M in transactions. Which Reviva Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($224K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 224,000 shares in the last 24 months. This volume of shares sold represents approximately $1.09M in transactions. Related Companies SLRN Major Shareholders KMDA Major Shareholders CGC Major Shareholders TRVI Major Shareholders ETON Major Shareholders AQST Major Shareholders TNGX Major Shareholders SAGE Major Shareholders JSPR Major Shareholders VALN Major Shareholders This page (NASDAQ:RVPH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
